Amgen and UCB re-file Evenity for US approval
The US FDA has approved a label extension for UCB’s Cimzia (certolizumab pegol) for adults with moderate-to-severe plaque psoriasis
Besponsa becomes first of its kind indicated for rare type of acute lymphoblastic leukaemia.
Byteflies’ Sensor Dot will help monitor brain, heart and respiration activity.
Sales of Protelos hit by safety restrictions.